the regimens used were bcmf ( bleomycin 15 mg i.v . for 3 days , cyclophosphamide 500 mg i.v. , methotrexate 50 mg i.v . and 5-fluorouracil 500 mg i.v . ) and cmu ( cyclophosphamide 350 mg/m2 i.v. , methotrexate 30 mg/m2 i.v . and uft 600 mg p.o . for 14 days ) .
C0025677
methotrexate
C0281491
cyclophosphamide